Contact
Please use this form to send email to PR contact of this press release:
ROSEN, A RANKED AND LEADING FIRM, Encourages Apellis Pharmaceuticals, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – APLS
TO: